This document summarizes a presentation on transcatheter closure of an atrial septal defect (ASD). A 65-year-old female patient presented with shortness of breath and occasional palpitations. Testing revealed a 14mm ASD with left-to-right shunting and right ventricular dilation. The patient underwent a successful transcatheter closure of the ASD using an 22mm Amplatzer device. The presentation covered recommendations for when closure is indicated based on defect size and shunt ratio, advantages of device closure over surgery, potential complications, and follow-up care after the procedure.
Transcatheter closure of atrial septal defect in symptomatic childrenRamachandra Barik
Atrial septal defect (ASD) constitutes 8%–10% of the
congenital heart defects in children. The secundum
ASD accounts for nearly 75% of all ASDs. Since
the introduction of transcatheter device closure for
secundum ASDs in 1976 by King et al., there has been
a paradigm shift in their management. Over the years,
the procedure has evolved significantly to become a
treatment of choice in many institutions. The Amplatzer
septal occluder (ASO) is the most widely used device
owing to its user-friendliness and high success rate.
Various studies have reported transcatheter closure
to be as effective, and with lower complication rate, as
compared to surgical closure.[4,5] However, most of these
studies have included bigger children, adolescents, and
adults. Although a few studies have demonstrated
the feasibility and reasonable safety of transcatheter
ASD device closure in very young children,[7-10] none of
them have addressed important issues like how large
a defect is too large for device closure, how to select
the size of the device, does the length of the interatrial
septum (IAS) matter in the device selection, and is
there a need for using modified techniques to achieve
successful deployment of the device in this subset of
patients which is characterized by relatively large defects
in small hearts.
Transcatheter closure of atrial septal defect in symptomatic childrenRamachandra Barik
Atrial septal defect (ASD) constitutes 8%–10% of the
congenital heart defects in children. The secundum
ASD accounts for nearly 75% of all ASDs. Since
the introduction of transcatheter device closure for
secundum ASDs in 1976 by King et al., there has been
a paradigm shift in their management. Over the years,
the procedure has evolved significantly to become a
treatment of choice in many institutions. The Amplatzer
septal occluder (ASO) is the most widely used device
owing to its user-friendliness and high success rate.
Various studies have reported transcatheter closure
to be as effective, and with lower complication rate, as
compared to surgical closure.[4,5] However, most of these
studies have included bigger children, adolescents, and
adults. Although a few studies have demonstrated
the feasibility and reasonable safety of transcatheter
ASD device closure in very young children,[7-10] none of
them have addressed important issues like how large
a defect is too large for device closure, how to select
the size of the device, does the length of the interatrial
septum (IAS) matter in the device selection, and is
there a need for using modified techniques to achieve
successful deployment of the device in this subset of
patients which is characterized by relatively large defects
in small hearts.
Our concepts of heart disease are based on the enormous reservoir of physiologic and anatomic knowledge derived from the past 70 years' of experience in the cardiac catheterization laboratory.
As Andre Cournand remarked in his Nobel lecture of December 11, 1956, the cardiac catheter was the key in the lock.
By turning this key, Cournand and his colleagues led us into a new era in the understanding of normal and disordered cardiac function in huma
This is a comprehensive description of coronay lesion assessment from routinely used angiography to advanced imaging modalities like IVUS/OCT including their functional significance by FFR
Our concepts of heart disease are based on the enormous reservoir of physiologic and anatomic knowledge derived from the past 70 years' of experience in the cardiac catheterization laboratory.
As Andre Cournand remarked in his Nobel lecture of December 11, 1956, the cardiac catheter was the key in the lock.
By turning this key, Cournand and his colleagues led us into a new era in the understanding of normal and disordered cardiac function in huma
This is a comprehensive description of coronay lesion assessment from routinely used angiography to advanced imaging modalities like IVUS/OCT including their functional significance by FFR
Patent ductus arteriosus (PDA) is a congenital disorder in the heart wherein a neonate's ductus arteriosus fails to close after birth. Early symptoms are uncommon, but in the first year of life include increased work of breathing and poor weight gain. With age, the PDA may lead to congestive heart failure if left uncorrected. The ductus arteriosus is a normal fetal blood vessel that closes soon after birth. In a patent ductus arteriosus (PDA) the vessel does not close and remains "patent" (open) resulting in irregular transmission of blood between two of the most important arteries close to the heart, the aorta and the pulmonary artery. PDA is common in neonates with persistent respiratory problems such as hypoxia, and has a high occurrence in premature children. In hypoxic newborns, too little oxygen reaches the lungs to produce sufficient levels of bradykinin and subsequent closing of the DA. Premature children are more likely to be hypoxic and thus have PDA because of their underdeveloped heart and lungs.
A patent ductus arteriosus allows a portion of the oxygenated blood from the left heart to flow back to the lungs by flowing from the aorta (which has higher pressure) to the pulmonary artery. If this shunt is substantial, the neonate becomes short of breath: the additional fluid returning to the lungs increases lung pressure to the point that the neonate has greater difficulty inflating the lungs. This uses more calories than normal and often interferes with feeding in infancy. This condition, as a constellation of findings, is called congestive heart failure.
In some cases, such as in transposition of the great vessels (the pulmonary artery and the aorta), a PDA may need to remain open. In this cardiovascular condition, the PDA is the only way that oxygenated blood can mix with deoxygenated blood. In these cases, prostaglandins are used to keep the patent ductus arteriosus open
2. 65 year old patient ,female
c/o : SOB, occasional palpitations
TEE: ASD II , Left to Right Shunt. Diameter of
defect 14 mm . RV dilated with signs of volume
overloading
Right heart Catheterization: PA sys 36mmHg
PVR 61 dyn/cm5
Balloon sizing :
5. Common 3-10% of CHD
Classification: ASD I, ASD II 70%, sinus venosus
Female > Male
Pathophsiology : initially left to right shunt
Clinical features and diagnostic evaluation:
are not the scope of this presentation!
6. Three questions crystallize the debate :
1. Who should have their ASD closed?
2. When should it be closed?
3. How should it be closed?
7. Any patient with dilated RV or RA by Echo,MRT
or CT
any ASD ( in the absence of of advanced
pulmonary HTN) with one or more of following:
1. ASD > 10 mm on TEE
2. Qp:Qs > 1.5:1
8. Yes close it and yes do it as soon as possible !
Is the age matter ? The answer is NO
9. The defect too small follow them periodically
Severe pulmonary arterial HTN ; do not close !
ASD acts here as ``pop-off`` valve
Pregnancy defer 6 months after delivery
Severe LV dysfunction . Again ASD functioning
as`` pop-off`` valve
10.
11. Device closure is a safe and effective procedure in
experienced hands
Advantages of device closure :
less hospital stay, avoidance surgical wounds, same
hemodynamic benefit as by surgery
Drawbacks: large defect > 36 mm, septal rim less
than 5 mm, proximity of defect to AV ,CS,IVC,SVC
12. Successful closure achieved in 95 % of Pt.
Tachyarrhythmia 1-4% follow up , ablation
Brady arrhythmia Pacing
Device migration and erosion : catastrophic but rare
0,1 %related to operator experience and over sizing
Right heart failure or progressive pulmonary HTN ;
related to the age of patient at the time of closure
Thrombosis 1.2 %: maximal at 4 weeks ,rare with
dual therapy era
Nickel allergy ! Chest pain at next day do skin test
if positive remove the device
13. Small: common after catheter closure ,close
spontaneously after 1 year
Large : false measurement, dehisced
ASD device
14. Dual antiplatelet therapy 6 months
TTE next day .
TEE in 1,6 and in 12 months
IE-prophylaxis for 6 months
15. Majority of ASD II are device closable
Safe and effective procedure
need for excellent pre-procedure work up